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Cesarean deliveryAbstract Background: Transversus abdominis plane (TAP) block provides sensory block from T6
to L1. It is one of the most widely used regional analgesic techniques and important component of
multimodal approach for postoperative analgesia in multiple lower abdominal surgeries.
Objective: To compare between the analgesic potency of ropivacaine 0.2% and ropivacaine 0.5%
when used in transversus abdominis plane (TAP) block for post operative analgesia after cesarean
delivery.
Patients and methods: Fifty parturients with American society of Anesthesiologists Physical Status
I or II aged between 25 and 35 years undergoing cesarean delivery with general anesthesia were
included in this prospective, randomized, double blind study. They were randomly divided into 2
groups according to the concentration of ropivacaine used in TAP block. The 1st group received
bilateral 20 ml of 0.2% ropivacaine while the 2nd received the same volume of 0.5% ropivacaine
at the end of the surgery. Intensity of postoperative pain at rest and during movement, time to
1st analgesic request, total dose of tramadol used, time to 1st mobilization from bed, parturients
satisfaction of pain management, and complications of TAP block were recorded.
Results: Visual Analogue Scale (VAS) at rest and during movement, time to 1st analgesic request,
total dose of tramadol, time to 1st mobilization from bed, patients satisfaction of pain management
were comparable between the two groups.
Conclusion: Ropivacaine 0.2% when used in TAP block provided postoperative analgesia similar
to ropivacaine 0.5% in TAP block after cesarean delivery.
 2016 Publishing services by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Postoperative pain after cesarean delivery represents a major
problem that facing both the obstetrician and the anesthesiolo-
gist; it is mainly related to the abdominal wall incision and dis-
section of the abdominal muscles [1]. Inadequate postoperative
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quent increased risk of thromboembolism, and harms mother–
baby relationship [2]. Goal standard for postoperative pain is
opioids whether administered systemic or neuraxial but it is
associated with many side effects such as nausea, vomiting, pru-
ritus, constipation, and respiratory depression [3]. Multimodal
approach of postoperative analgesia which combines par-
enteral analgesics with regional analgesic techniques may
enhance analgesia of each component and decrease its side
effects [4]. Transversus abdominis plane (TAP) block repre-
sents one of the most widely used regional analgesic techniques
and important component of multimodal approach for postop-
erative analgesia [5]. Transversus abdominis plane (TAP) is a
neurovascular plane between the internal oblique muscle and
the transversus abdominis muscle through which pass the
nerves supplying the anterolateral abdominal wall [6]. Applica-
tion of the local anesthetics in this plane will produce myocuta-
neous sensory block between T6 and L1 (TAP) block which is
suitable for pain relief in abdominal surgeries [7]. TAP block
was described for the 1st time by Rafi in 2001; he called the
technique as refined abdominal field block. TAP block has been
used successfully as an important element of multimodal post-
operative analgesia for many abdominal procedures such as
cholecystectomy, gynecological laparoscopy, appendectomy,
nephrectomy, and cesarean delivery [8].
Establishment of TAP block requires injection of large dose
of LA in this relatively vascular plane which leads to potential
neurotoxic plasma level of the LA [9], especially during preg-
nancy which increases susceptibility of the pregnant women
to local anesthetic toxicity [10].
The aim of this study was to compare between ropivacine
0.2% and ropivacaine 0.5% as regards their analgesic potency
and safety when they used in TAP block for postoperative
analgesia after cesarean delivery performed under general
anesthesia.
2. Patients and methods
This prospective, randomized, double blinded study was per-
formed in El –Minia university hospital in the period from July
2014 to July 2015. After obtaining approval of the local ethics
committee of the faculty of medicine and informed written
consents from all the parturients, fifty parturients ASA I or
II aged from 25 to 35 years scheduled for cesarean delivery
under general anesthesia. Parturients with coagulopathy, infec-
tion in the site of the block, allergy to LA used, or sensitivity to
prescribed analgesics, who are unable to understand visual
analogue scale (VAS) were excluded.
Parturients included in the study were randomly allocated
into two equal groups according to the concentration of the
ropivacaine used in TAP block by random allocation software
(windows software, version 1.0, May 2004). The allocation
ratio was 1:1 and the group identification cards were put in
sealed and opaque envelops to hide allocation. The local anes-
thetic solution was made by the pharmacist in a glass bottle
labeled as A or B. Parturients were injected with 20 ml of this
solution in each side in the TAP. At the end of the study these
labels were known from the pharmacist that A was ropivacine
0.2% while B was ropivacaine 0.5%. Anesthesiologist, parturi-
ents, and nursing staff who follow up the parturients
were blinded with the concentration of ropivacaine used.Parturients were instructed to use Visual Analogue Scale
(VAS) 0/10 to assess the post operative pain, where 0 repre-
sents no pain while 10 represents the worst possible pain. Par-
turients were cannulated when they entered the operation
room and they preoxygenated for 3 min through face mask.
Standard monitoring (pulse oximetry, electrocardiogram,
capnography, and non invasive blood pressure measurement)
was applied to the parturients. Induction of anesthesia was
done by thiopental 5 mg/kg and succinylcholine 1 mg/kg fol-
lowed by tracheal intubation with suitable size of endotracheal
tube with cricoid pressure. Maintenance of anesthesia was
done by isoflurane 1% and atracurium 0.25 mg/kg to maintain
train–of- four (TOF) at 1 throughout the surgery using periph-
eral nerve stimulator and mechanical ventilation was adjusted
to keep end-tidal PaCo2 at 35–45 mmHg. After delivery of the
baby, the parturients received 5 international units (I.U) bolus
dose of oxytocin and 40 I.U as continuous infusion. 1 lg/kg
fentanyl was administered to the parturients after delivery.
At the end of the surgery and after wound closure TAP block
was performed by the guidance of ultrasound device CHISON
Ultrasound Diagnostic System model ECO 3 Chison Medical
Imaging Co., Ltd. No 8, XIANG NAN ROAD, SHUO
FANG, NEWDistrict, WUXI, China, 214142 with broadband
linear array probe 6–11 MHz.
2.1. Technique of TAP block
After complete disinfection and sterilization of the entry site
which located in the midaxillary line midway between the
costal margin and the iliac crest, 150 mm Stimuplex needle
(B-Braun Medical, Bethlehem, PA, USA) was advanced in
the neurofascial plane between the internal oblique muscle
and transversus abdominis muscle using plane technique. Once
the needle was introduced in the correct place 20 ml of the LA
solution was injected. Visualization of hypoechoic layer
between the two muscles on injection of the local anesthetic
solution was considered as the end point of success of the
block [11]. This procedure was repeated on the other side.
After the end of the TAP block anesthesia was terminated
and neuromuscular block was antagonized by 2.5 mg neostig-
mine plus 1 mg atropine, then extubation was done when air-
way reflexes returned. Parturients considered awake when they
could open their eyes on command.
Parturients were transferred to the post anesthesia care unit
(PACU) where they were observed by nursing staff blinded
with the concentration of LA used. Parturients received anal-
gesic regimen of 1 gm of intravenous paracetamol/24 h, and
diclofenac 75 mg I.V infusion/8 h starting from the time of
admission to PACU to overcome the visceral component of
postoperative pain. Parturients were advised that they could
ask for a rescue analgesic dose if the VAS was >4 at any time.
The rescue analgesic dose was bolus dose of 0.5 mg/kg of tra-
madol hydrochloride though intravenous route.
3. Parameters assessed
1. Intensity of pain using visual analogue scale (VAS)
where 0-no pain or 10 = maximum sever pain during
rest and during movement (passive flexion of hip and knee)
at 30 min, 1, 2, 4, 8, 12, 24 h after admission to the
PACU.
Assessment of the analgesic potency of ropivacaine 0.2% versus 0.5% 3872. Time to 1st analgesic request (time from TAP block), num-
ber of analgesic doses in the 1st 24 h, and total dose of tra-
madol hydrochloride in the 1st 24 h.
3. Time to 1st mobilization from bed after surgery.
4. Parturients satisfaction of pain management according to
patient satisfaction scale where 0 = very unsatisfied and
10 = highly satisfied at the time of discharge.
5. Symptoms of LA toxicity e.g. numbness, tingling, or
arrhythmia.
6. Complication of TAP block technique such as hematoma,
infection, pain at site of entry, and visceral injury.
4. Sample size calculation
Using Power Analysis and Sample Size System (PASS) soft-
ware (NCSS, East Kaysville, Utah, USA), it was found that
the least number of parturients required in each group to
detect three scores difference in VAS with 95% power and
0.05% significance level was 22 parturients with 10% dropout
ratio, and the number increased to 25 parturients in each
group.
4.1. Statistical analysis
Data were expressed as mean ± SD, or number and percent-
age. Data were analyzed with SPSS version 21 (SPSS Inc.,
Chicago, IL, USA).
Data were tested for normal distribution by Kolmogorov-
Smirnov test. One-way analysis of variance (ANOVA) was
used to analyze normally distributed continuous data. None
of normally distributed data were analyzed by chi-square or
Fisher’s exact test. All tests are two-tailed. P value of <0.05
was considered significant.
5. Results
A total number of 50 parturients were randomized for the
study in the period from January 2014 to July 2015. None of
the parturients were excluded from the study nor lost follow
up nor lost analysis Fig. 1.
There was no significant difference between the two groups
as regards characteristics of the parturients or number of the
cesarean. The average time of the surgery was 55 ± 11 min
in group 0.2% ropivacaine and was 57 ± 8 min in 0.5% ropi-
vacaine with no significant difference Table 1. There was no
significant difference between the two groups as regards the
time of the 1st request of analgesic dose where it was 4.2
± 0.3 h in group 0.2% ropivacaine and 4.3 ± 0.4 in group
0.5% ropivacaine Table 2. Time to 1st mobilization from
bed was 2.3 ± 0.6 h in group 0.2% ropivacaine while it was
2.1 ± 0.5 h in group ropivacaine 0.5% with no significant dif-
ference between the two groups. There was no significant dif-
ference between the two groups as regards the total dose of
tramadol hydrochloride as it was 160 ± 10 mg in 0.2% ropiva-
caine group and 150 ± 9 mg in 0.5% ropivacaine group. As
regards the patient satisfaction score there was no significant
difference between the two groups as it was 7.8 ± 1.2 in
0.2% ropivacaine group while it was 8 ± 1.4 in 0.5% ropiva-
caine group. There was no significant difference between thetwo groups as regards VAS whether at rest or during move-
ment (see Tables 3–5).
6. Discussion
This study compared two ropivacaine concentrations 0.2%
and 0.5% as regards their postoperative analgesic potency
when used for TAP block after cesarean delivery performed
under general anesthesia and it was found that the two concen-
trations provided nearby postoperative analgesia after cesar-
ean delivery as shown by VAS and patients satisfaction. The
volume of the local anesthetic LA which injected in TAP
was selected to be 20 ml in each side which coincides with
Moeschler et al. [12] in their study on cadavers, in which they
injected different volumes of contrast in TAP and they con-
cluded that the increased volume of the injected contrast would
increase the cranio-caudal spread and would reach iliohy-
pogastric nerve, and intercostals nerve which increase the inci-
dence of success rate of the TAP block and they suggested that
15 ml of LA may be the optimal volume of LA to provide ade-
quate TAP block. In this study the volume was increased to
20 ml in each side to compensate for the possible intramuscu-
lar spread of the LA.
Chen and Phui [13] found that injection of 20 ml of ropiva-
caine 0.375% for TAP block was effective as intraoperative
and postoperative analgesic in 10 cases of laparoscopic chole-
cystectomy even after they were diverted to open
cholecystectomy.
This coincides with Abdul Jalil et al. [14] in their prospec-
tive, randomized, double blind study on 56 parturients sched-
uled for appendectomy under general anesthesia and they
received TAP block with ropivacaine 0.2% in one group and
ropivacaine 0.5% in the other group at the end of the surgery
and they found that both concentrations provided comparable
postoperative analgesia.
Also this coincided with Oliviera et al. [15] in their prospec-
tive randomized, double blinded, placebo controlled study on
98 females scheduled for outpatient gynecological laparoscopy
in which they compared between ropivacaine 0.25 and ropiva-
caine 0.5% in TAP block to provide postoperative analgesia
and they found that there was no significant difference between
the two concentrations in their analgesic potency and no sig-
nificant difference in parturients satisfaction score between
the two concentrations.
Sirvasta et al. [16] in their randomized double blind study
on 62 pregnant women scheduled for cesarean delivery to
assess the role of TAP block as a component of multimodal
postoperative analgesia and they found that the TAP block
significantly decreased pain score at all study times during rest
and movement and also decreased parturients consumption of
tramadol through patient controlled analgesia.
McDonnell et al. [17] in their study evaluated the effective-
ness of TAP block with ropivacaine for postoperative analge-
sia in cesarean delivery performed under spinal anesthesia, and
they found that TAP block significantly decreased the pain
score and 48 h morphine consumption.
In this study there were no complications of the TAP block
technique as hematoma, infection, visceral injury, and vascular
injury, and this may be caused by ultrasound guidance of the
procedure, but this does not mean the complete safety of the
procedure as Farok and Carey [18] reported hepatic trauma
Figure 1 Flowchart of the study.
Table 1 Parturients characteristics.
Item Group ropivacaine
0.2% (n= 25)
Group ropivacaine
0.5% (n= 25)
P
value
Age (years) 32.5 ± 4.0 32 ± 5 0.877
Weight (kg) 77.8 ± 9.4 78 ± 8.3 0.937
Height (cm) 166 ± 4.4 165 ± 4 0.405
Number of C.S
1st 7 (60%) 15 (60%) 0.875
2nd 15 (28%) 8 (32%)
3rd 3 (12%) 2 (8%)
Duration of
surgery (min)
55 ± 11 57 ± 8 0.466
Data were expressed as mean ± SD for continuous variables.
Number of cesarean section was expressed as number and
percentage.
Table 2 Time to 1st analgesic request, and 1st mobilization.
Item Group
ropivacaine 0.2%
(n= 25)
Group
ropivacaine 0.5%
(n= 25)
P
value
Time to 1st
analgesic request
(h)
4.2 ± 0.3 4.3 ± 0.4 0.322
Time to 1st
mobilization (h)
2.3 ± 0.6 2.1 ± 0.5 0.207
Data were expressed as mean ± SD for continuous variables.
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hematoma formation in the entry site.
This study had many limitations. The 1st limitation it was
not possible to limit the intramuscular spread of LA solutionby the pressure of injection and incomplete separation of the
fascial plane which may affect the end result of the amount
of LA involved in TAP block [20].
The 2nd limitation was that the study could not eliminate
the psychic factor of baby which strongly affects the mother
in our locality and could encourage and motivate the mother
to tolerate pain and move if male baby.
The 3rd was that the study could not stabilize the severity
of surgical trauma or severity of uterine contractions which
led to variability of pain severity. The study duration was
Table 3 Total dose of tramadol hydrochloride, number of analgesic doses, and patients satisfaction of pain management score.
Item Group 0.2% ropivacaine (n= 25) Group 0.5% ropivacaine (n= 25) P value
Total dose of tramadol hydrochloride (mg) 160 ± 10 155 ± 9 0.069
Number of analgesic doses 2.2 ± 0.6 2 ± 0.5 0.207
Patients satisfaction of pain management score 7 (5–9) 8 (6–9) 0.590
Data are expressed as mean ± SD.
Table 4 Visual Analogue Scale (VAS) during rest.
Time Group ropivacaine 0.2% Group ropivacaine 0.5% P value
Admission to PACU 1.4 ± 0.4 1.4 ± 0.3 1
30 min after admission to PACU 1.6 ± 0.3 1.5 ± 0.3 0.244
1 h after admission to PACU 1.8 ± 0.5 1.7 ± 0.4 0.439
2 h after admission to PACU 2.0 ± 0.5 1.9 ± 0.4 0.439
4 h after admission to PACU 1.9 ± 0.6 1.6 ± 0.5 0.061
8 h after admission to PACU 1.6 ± 0.6 1.6 ± 0.6 1
12 h after admission to PACU 1.4 ± 0.4 1.4 ± 0.4 1
24 h after admission to PACU 1.1 ± 0.4 1.1 ± 0.3 1
Data are expressed as mean ± SD.
Table 5 Visual Analogue Scale (VAS) during movement.
Time Group ropivacaine 0.2% (n= 25) Group ropivacaine 0.5% (n= 25) P value
Admission to PACU 3.4 ± 1.5 3.3 ± 1.6 0.821
30 min after admission to PACU 3.8 ± 1.1 3.5 ± 1.3 0.383
1 h after admission to PACU 3.4 ± 1.5 3.4 ± 1.5 1
2 h after admission to PACU 3.7 ± 1.6 3.7 ± 1.4 1
4 h after admission to PACU 3.2 ± 1.4 3.1 ± 1.1 0.780
8 h after admission to PACU 3.0 ± 1.5 3.0 ± 1.4 1
12 h after admission to PACU 2.5 ± 1.3 2.1 ± 1.1 0.246
24 h after admission to PACU 2.4 ± 1.4 2.2 ± 1.3 0.603
Data are expressed as mean ± SD.
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turients and their relatives to return home as early as possible.
7. Conclusion
Bilateral 20 ml of ropivacaine 0.2% when used in TAP block
provided postoperative analgesia similar to bilateral 20 ml of
ropivacaine 0.5% in TAP block after cesarean delivery per-
formed with general anesthesia.
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